| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | DataBahn | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $58.08M | Series B | 7/30/2026 | $39.08M | $255.36M | $3.26 | Insight Partners, Forgepoint Capital, GTM Capital, S3 Ventures | ||||
 | Delos Data | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $133.4M | Series A | 9/15/2026 | $100M | $332.2M | $5.61 | Matrix, Playground Global, Socratic Partners, Capricorn Investment Group, Matter Venture Partners, IAG, Dynamiq | ||||
 | Delve | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $35.44M | Series A-1 | 7/22/2025 | $32M | $300M | $19.90 | Insight Partners | ||||
 | Deserve | Fintech Lending | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $262.68M | Series EE | 1/23/2025 | $18.38M | $255.19M | $2.02 | Undisclosed Investors | ||||
 | Doceree | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $45.11M | Series B-2 | 9/27/2023 | $7.5M | $271.1M | $104.20 | Creaegis, Eight Roads Ventures, F-Prime Capital | ||||
 | ElectraDx | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $46.77M | Series B | 11/14/2025 | $32M | $270.54M | $7.31K | TAUNS Laboratories | ||||
 | Farcast Biosciences | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $79.8M | Series B | 7/11/2018 | $73.28M | $153.24M | $0.35 | Northpond Ventures, Accel, Sequoia Capital, Sands Capital Ventures, RA Capital Management | ||||
 | Fast Radius | Industrial Manufacturing | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $61.21M | Series B | 4/2/2019 | $48.02M | $392.68M | $13.49 | Drive Capital, Hyde Park Venture Partners, Jump Capital, SkyDeck, UPS Strategic Enterprise Fund | ||||
 | Flyhomes | Real Estate Real Estate Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $208.35M | Series D | 7/30/2025 | $15M | $112.29M | $0.38 | Andreessen Horowitz, Norwest, Canvas Prime, Camber Creek, Al Goldstein, Mark Vadon | ||||
 | Freshpaint | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $41.85M | Series B | 7/16/2024 | $30.7M | $234.85M | $8.47 | Threshold Ventures, SignalFire, Intel Capital, Zero Prime Ventures, Y Combinator | ||||
 | Geltor | Industrial Materials | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $9.3M | Series A-1 | 12/12/2024 | $5.5M | $10.91M | $0.10 | Undisclosed Investors | ||||
 | Gladly | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $211.21M | Series F | 9/26/2024 | $40M | $415.36M | $2.46 | AXA Venture Partners | ||||
 | GoodData | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $232.50K | -- | 1 | Not available | -- | -- | $120.59M | Series F | 11/19/2018 | $21.84M | $311.72M | $2.08 | Zendesk | ||||
 | Great Expectations | Enterprise Software Data Management / Storage | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $65.18M | Series B | 2/10/2022 | $40M | $349.63M | $16.35 | Tiger Global, Index Ventures, CRV, Root Ventures | ||||
 | Hazel Health | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $364.29M | Series E | 6/9/2026 | $99.03M | $396.96M | $2.40 | Undisclosed Investors | ||||
 | HealthTap | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $93.45M | Series B | 11/6/2024 | $28.05M | $44.1M | $0.21 | Undisclosed Investors | ||||
 | HG Insights | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $21.76M | Series B-1 | 3/24/2016 | $3.53M | $75.09M | $0.47 | Updata Partners, Rincon Venture Partners, Epic Ventures | ||||
 | Hungry | Foodtech Other Foodtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $70.44M | Series C-2 | 5/28/2024 | $5.08M | $318.97M | $6.18 | Astanor, Koru Capital, Virginia Innovation Partnership Corporation | ||||
 | Immune-Onc Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $143.15M | Series B3 | 1/6/2023 | $30M | $262.2M | $2.11 | Triwise Capital, Proxima Ventures | ||||
 | Imperfect Foods | Foodtech Food Products & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $321.35M | Series E | 10/31/2022 | $60.2M | $178.07M | $2.90 | Undisclosed Investors | ||||
 | Inflammatix | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $186.19M | Series E-2 | 9/12/2024 | $26.2M | $210.31M | $0.15 | Khosla Ventures, Think.Health Ventures, Northpond Ventures, D1 Capital Partners, Iberis Capital, Vesalius BioCapital, OSF Healthcare Ventures, RAW Ventures | ||||
 | Inquis Medical | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $141.46M | Series C | 1/12/2026 | $75M | $370.67M | $0.86 | Undisclosed Investor | ||||
 | InstaLILY | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $88.5M | Series B | 7/14/2026 | $60.5M | $383.14M | $24.99 | Energize Capital, Insight Partners, Home Depot Ventures, United Rentals | ||||
 | Jace | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $77.85M | Series A-1 | 5/19/2026 | $66.24M | $434.37M | $25.97 | Accel, Bek Ventures, Kaya VC, Inovo VC, Tenacity Capital, Stewart Butterfield, Cal Henderson, Victor Riparbelli, Lenny Rachitsky, Shaan Puri, Charlie Songhurst, NFDG, Koen Bok, Mati Staniszewski, Guillermo Rauch, Alex Bouaziz, Max Mullen, Joel Hellermark, Harry Stebbings | ||||